In a 6-year-old with reactive airway disease and upper respiratory infection symptoms, PEWS score 3, who received dexamethasone and a duoneb an hour ago and still has retractions while on oxygen, what additional emergency department management should be initiated when starting high-flow nasal cannula?

Immediate Management Recommendations

Increase the frequency of nebulized bronchodilators to every 15-30 minutes and add ipratropium bromide immediately 1. This child is demonstrating severe reactive airway disease that has not responded adequately to initial therapy.

Critical Next Steps

1. Intensify Bronchodilator Therapy

Since the patient is not improving after 1 hour of duoneb treatment:

• Give nebulized β-agonist (albuterol/salbutamol) every 15-30 minutes 1
• Add ipratropium 100-250 mcg to each nebulizer treatment (dose adjusted for 6-year-old; guidelines suggest 100 mcg for children, up to 500 mcg for adults) 1
• Continue ipratropium every 6 hours until improvement starts 1
• All nebulizers should be oxygen-driven to maintain SpO2 >92% 1

2. Optimize Corticosteroid Therapy

The patient has received dexamethasone, but may need additional dosing:

• Continue or add prednisolone 1-2 mg/kg/day (maximum 40 mg) if not already given adequate oral steroid dose 1
• If the patient appears severely ill or cannot tolerate oral medication, consider IV hydrocortisone 1
• The dexamethasone already given is appropriate, but ensure adequate anti-inflammatory coverage continues

3. Consider IV Aminophylline for Life-Threatening Features

Assess for life-threatening features (cyanosis, silent chest, poor respiratory effort, exhaustion, altered consciousness):

• If present: Give IV aminophylline 5 mg/kg over 20 minutes, followed by 1 mg/kg/hour maintenance infusion 1
• Omit loading dose if patient already receiving oral theophyllines 1

4. Monitoring Requirements

• Maintain continuous pulse oximetry with target SpO2 >92% 1
• Monitor respiratory rate, work of breathing, and retractions every 15-30 minutes initially
• PEWS score reassessment at 90 minutes after HFNC initiation is critical - high or worsening scores indicate non-response and need for PICU transfer 2
• Chart response before and after each nebulizer treatment 1

5. Prepare for Potential PICU Transfer

Have a low threshold for ICU consultation if:

• Deteriorating respiratory status despite aggressive therapy
• Worsening or persistent hypoxia on high-flow
• Exhaustion, confusion, or altered mental status
• Persistent severe retractions despite treatment
• PEWS respiratory score >2.7 or worsening at 90 minutes post-HFNC initiation 2

Important Clinical Considerations

Common Pitfall: Waiting too long between bronchodilator treatments. The guidelines explicitly state that when patients are not improving after 15-30 minutes, bronchodilators should be given every 15-30 minutes, not every 4-6 hours 1. This aggressive approach is essential for severe exacerbations.

Ipratropium Addition: This is a critical intervention often overlooked. The anticholinergic effect complements β-agonist therapy and should be added immediately when initial treatment fails 1.

High-Flow Nasal Cannula Context: While you're starting HFNC (appropriate for ongoing oxygen requirement), this does not replace the need for aggressive pharmacologic bronchodilator therapy. HFNC provides respiratory support but doesn't treat the underlying bronchospasm 2.

Steroid Timing: The dexamethasone given earlier is appropriate, but ensure the patient receives adequate ongoing corticosteroid coverage with oral prednisolone or IV hydrocortisone 1.

Age-Specific Dosing: For a 6-year-old, use full pediatric doses: salbutamol 5 mg or terbutaline 10 mg per nebulizer (not half-doses, which are for very young children) 1.